Latest Breaking News On - Bridgebio pharma - Page 5 : comparemela.com

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) saw a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 16,230,000 shares, a growth of 7.7% from the April 15th total of 15,070,000 shares. Currently, 11.5% of the company’s stock are sold short. Based on an […]

United statesBridgebio pharmaRandalw scottRaymond jamesBio pharmaBridgebio pharma incSecurities exchange commissionPricet rowe associates incComerica bankJpmorgan chase coJanus henderson groupGet free reportBio pharma trading downDirector randalExchange commissionState teachers retirement system